The Gretener-Thürlemann Prize honors scientists from around the world for their outstanding achievements in medicine (basic research), medicine (clinical/translational), chemistry and physics. The prize, which will be awarded for the first time in 2025, will honor achievements in the field of medicine (clinical/translational) this year. The amount of the prize is 500,000 Swiss francs.

The Gretener-Thürlemann Foundation, established in 2018, is funded by the legacy of Dr. Adolf and Adelheid Gretener-Thürlemann. The Zurich couple shared a keen interest in science and research throughout their lives.

Adolf Gretener (born in 1926) studied medicine at the University of Zurich (UZH) and worked as a general practitioner. Adelheid Gretener-Thürlemann's family was active in the construction industry. Their shared enthusiasm for science led to the establishment of the foundation, which aims to promote long-term research.

• Honors outstanding scientists for foundational and pioneering research of societal benefit
• Awarded by the University of Zurich
• Given annually with a rotating focus in the fields of medicine (basic research), medicine (clinical/translational), chemistry and physics
• To be awarded for the first time in 2025 in the field of translational/clinical medicine
• Nomination of individuals or teams (up to three researchers)
• Financial award of 500,000 Swiss francs, to be divided equally in the case of multiple awardees

The award ceremony of the Gretener-Thürlemann Prize will take place in Zurich on Wednesday, December 3, 2025.

To the nomination

FAQs